| Net Income (Loss) Per Share |
Net Income (Loss) Per Share The following table sets forth the computation of basic and diluted income (loss) per share: | | | | | | | | | | | | | Three Months Ended
March 31, | | 2025 | | 2024 | | Numerator: | | | | | Net income (loss) and comprehensive income (loss) | $ | 27,019 | | | $ | (9,406) | | | Gain on fair value of warrant liabilities | (9,905) | | | — | | | Net income (loss) and comprehensive income (loss) adjusted for gain on fair value of warrant liabilities | $ | 17,114 | | | $ | (9,406) | | | Denominator: | | | | Basic weighted average shares of common stock outstanding | 189,767,679 | | | 175,516,307 | | Diluted effect of stock-based awards | 3,614,345 | | | — | | | Diluted effect of warrants | 7,371,766 | | | — | | Diluted effect of market condition equity awards | 111,574 | | | — | | Diluted effect of KPI awards | 182,726 | | | — | | Diluted weighted average shares of common stock outstanding | 201,048,090 | | | 175,516,307 | | | | | | | Net income (loss) per share | | | | | Basic | $ | 0.14 | | | $ | (0.05) | | | Diluted | $ | 0.09 | | | $ | (0.05) | |
The following table presents the potential shares that are excluded from the computation of diluted net income (loss) per share and comprehensive income (loss) per share for the periods presented because including them would have had an anti-dilutive effect: | | | | | | | | | | | | | Three Months Ended
March 31, | | 2025 | | 2024 | | Stock options issued under 2020 Plan | — | | | 1,563,577 | | | Time-based RSUs | — | | | 6,112,074 | | | | | | | Warrants | — | | | 37,360,000 | |
|